Lung Cancer Organoids As Avatars of Patients With Lung Cancer in the Prediction of Therapeutic Response

Overview

Journal JTO Clin Res Rep

Date 2023 Oct 16

PMID 37842325

Authors

Rafael Rosell

Carlos Pedraz-Valdunciel

Affiliations

Soon will be listed here.

References

Ghosh S, Fan F, Powell R, Roszik J, Park Y, Stephan C . Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer. Mol Cancer Ther. 2023; 22(8):962-975. DOI: 10.1158/1535-7163.MCT-23-0110. View

Adachi Y, Kimura R, Hirade K, Yanase S, Nishioka Y, Kasuga N . Scribble mis-localization induces adaptive resistance to KRAS G12C inhibitors through feedback activation of MAPK signaling mediated by YAP-induced MRAS. Nat Cancer. 2023; 4(6):829-843. DOI: 10.1038/s43018-023-00575-2. View

Muller N, Lorenz C, Ostendorp J, Heisel F, Friese U, Cartolano M . Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer. Cancer Res. 2023; 83(15):2471-2479. DOI: 10.1158/0008-5472.CAN-22-2605. View

Xue J, Zhao Y, Aronowitz J, Mai T, Vides A, Qeriqi B . Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition. Nature. 2020; 577(7790):421-425. PMC: 7308074. DOI: 10.1038/s41586-019-1884-x. View

Koga T, Soh J, Hamada A, Miyano Y, Fujino T, Obata K . Clinical Relevance of Patient-Derived Organoid of Surgically Resected Lung Cancer as an In Vitro Model for Biomarker and Drug Testing. JTO Clin Res Rep. 2023; 4(9):100554. PMC: 10480534. DOI: 10.1016/j.jtocrr.2023.100554. View

Canon J, Rex K, Saiki A, Mohr C, Cooke K, Bagal D . The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature. 2019; 575(7781):217-223. DOI: 10.1038/s41586-019-1694-1. View

Chen J, Chu X, Zhang J, Nie Q, Tang W, Su J . Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients. Thorac Cancer. 2020; 11(8):2279-2290. PMC: 7396373. DOI: 10.1111/1759-7714.13542. View

Yin S, Xi R, Wu A, Wang S, Li Y, Wang C . Patient-derived tumor-like cell clusters for drug testing in cancer therapy. Sci Transl Med. 2020; 12(549). DOI: 10.1126/scitranslmed.aaz1723. View

Clements M, Holtslander L, Edwards C, Todd V, Dooyema S, Bullock K . HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer. Oncogene. 2021; 40(34):5314-5326. PMC: 8403155. DOI: 10.1038/s41388-021-01931-1. View

10.

Pauli C, Hopkins B, Prandi D, Shaw R, Fedrizzi T, Sboner A . Personalized and Cancer Models to Guide Precision Medicine. Cancer Discov. 2017; 7(5):462-477. PMC: 5413423. DOI: 10.1158/2159-8290.CD-16-1154. View

11.

Kwon J, Hajian B, Bian Y, Young L, Amor A, Fuller J . Structure-function analysis of the SHOC2-MRAS-PP1C holophosphatase complex. Nature. 2022; 609(7926):408-415. PMC: 9694338. DOI: 10.1038/s41586-022-04928-2. View